Science is breaking down how cannabis helps treat different medical conditions

308 0

The different components of cannabis target different ailments to improve health

Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) are well known today. However, scientists do not want to exclude those other minor cannabinoids, among the 100-200 that have been identified, to analyze how they may influence the treatment of different health and wellness conditions. This new research and information could pave the way for marijuana companies to sell a wider variety of products.

Cannabis products need not be limited to the benefits offered by THC and CBD, which are very common compounds on store shelves today. Minor cannabinoids such as CBN and THCV can also offer a host of health benefits to humans, and science is trying to explain how.

Through new products such as vaporizers and edibles, marijuana companies are attracting consumers looking for ways to address conditions such as obesity, insomnia, and nausea. Mike Hennesy, VP of Innovation for Colorado-based edibles manufacturer Wana Brands, said, “We’re better trying to understand which plants elicit what effects and how to consistently provide that to consumers so we can get away from all the meaningless strain names and get right to the point of how do you want this plant to help you feel.”

On the other hand, experts are looking closely to determine how other minor cannabinoids may be effective for certain conditions, from epilepsy and traumatic brain injury to other conditions that have yet to be identified. For example, cannabigerol (CBG) has been found to be ideal for combating inflammation, pain and nausea. Cannabinol (CBN) is known to be a sleeping pill or sedative, while tetrahydrocannabivarin (THCV), called “diet weed,” can help you control and lose weight.

The appetite for these cannabinoids is growing, and best of all, none of them have the same psychotropic effect as THC. The US market for minor cannabinoids amounted to $4.9 billion in 2020, according to reports from San Francisco-based market research and consulting firm Grand View Research.